Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
79 /100
CRITICAL RISK
Score updated Oct 13, 2026

PSTV — Plus Therapeutics, Inc. Dilution Risk Tracker

Track PSTV dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PSTV — Get alerts when the score changes →

As of October 13, 2026, Plus Therapeutics, Inc. (PSTV) has a DilutionWatch DilutionScore of 79/100, rated CRITICAL dilution risk. Plus Therapeutics, Inc. has a market capitalization of $40.06M, 7.59M shares outstanding, 24 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $15.00B, 1.82M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
85
📊 Float Risk
25
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 42%
💰 Capital Raise model 55%
• Low cash runway: 4 months remaining
• Active shelf registration ($15000M, 37444% of market cap)
📜 Warrant Exercise model 40%
• Significant warrants: 24% of shares outstanding
• Elevated warrant risk score (70/100)
📉 Score Deterioration model 15%
• Score already CRITICAL (79/100) — events likely imminent
🔔 Track PSTV — Get forecast alerts →

Market Data

Market Cap$40.06M
Shares Outstanding7.59M
Float6.46M
Cash$8.59M
Debt$7.38M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore79/100DilutionWatch score record
Shares Outstanding7.59MVerified float table or market cache
Public Float6.46MVerified float table or market cache
Market Cap$40.06MMarket data cache
Cash Runway4.5 monthsDilutionWatch score inputs
Shelf Capacity$15.00BSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants1.82MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 3 1, 4 4, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 0.1% shares (2026Q1 vs prior)
24 institutional holders · 11.56M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 4.85M shares
#2 GEODE CAPITAL MANAGEMENT, LLC 2.02M shares
#3 BlackRock, Inc. 1.78M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2017-03-24
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-04-01
3 FORM3 2026-03-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual PSTV Dilution Snapshot

Plus Therapeutics, Inc. (PSTV) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

PSTV's DilutionScore is currently 79/100 (Critical risk), with 3 score changes tracked over 89 days. The score improved from 73/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202679/100CRITICAL16 days
Aug 22 – Sep 27, 202673/100HIGH37 days
Aug 14 – Aug 21, 202677/100CRITICAL7 days
Jul 16 – Aug 13, 202675/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

PSTV shares outstanding have decreased 96.1% from 178.37M (Mar 2026) to 6.88M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 29, 20266.88M6.46M▲ 2.12%
Apr 18, 20266.86M6.33M▼ 0.23%
Apr 05, 20266.86M6.34M▼ 0.04%
Apr 03, 20266.86M6.34M▼ 96.00%
Mar 17, 2026178.37M158.56M▼ 0.25%
Mar 14, 2026178.37M158.95M▲ 24.83%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track PSTV Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment PSTV files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking PSTV — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for PSTV
PSTV FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.